Emtricitabine / Tenofovir alafenamide Viatris is an antiviral medicine used in combination with other medicines to treat individuals infected with human immunodeficiency virus type 1 (HIV\-1\), a virus that causes acquired immune deficiency syndrome (AIDS). It is used in adults and adolescents aged 12 years and older who weigh at least 35 kg. Emtricitabine / Tenofovir alafenamide Viatris contains the active substances emtricitabine and tenofovir alafenamide and is a ‘generic medicine’. This means that Emtricitabine / Tenofovir alafenamide Viatris contains the same active substances and works in the same way as a ‘reference medicine’ already authorised in the EU. The reference medicine for Emtricitabine / Tenofovir alafenamide Viatris is Descovy.
Therapeutic Indication
Emtricitabine/Tenofovir alafenamide Viatris is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (HIV\-1\).
Therapeutic Area (MeSH)
ATC Code
J05AR17
ATC Item
N/A
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
INN / Common Names
EMA Name
Emtricitabine / Tenofovir alafenamide Viatris
Medicine Name
Emtricitabine / Tenofovir alafenamide Viatris
Aliases
N/ANo risk management plan link.
